Lv0
0 积分 2025-03-02 加入
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
4小时前
已完结
Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate stage hepatocellular carcinoma with microvascular invasion: A multicenter cohort study
6小时前
已完结
Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic area
6小时前
已完结
Significance of anatomical resection and wide surgical margin for HCC patients with MVI undergoing laparoscopic hepatectomy: a multicenter study
6小时前
已完结
Therapeutic advances in hepatocellular carcinoma: an update from the 2024 ASCO annual meeting
7小时前
已完结
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion
13小时前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
13小时前
已完结
Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1
1天前
已完结
皖公网安备34019202002308
